This article is more than 5 years old. Information may no longer be current.

Patients with Sjögren’s more likely to develop lymphoma

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

PHILADELPHIA – Patients with Sjögren’s syndrome are 46 times more likely to develop lymphoma, according to a presentation made here at the PRIMARY CARE OPTOMETRY NEWS Symposium.

Presenters J. James Thimons, OD, FAAO, and Ernest Bowling, OD, MS, FAAO, addressed etiology, symptoms and treatment of various ocular surface diseases.

Dr. Bowling cited a study by Moutsopolous and colleagues, which found that Sjögren’s syndrome patients have an 8% to 11% incidence of lymphoma, which is 46.3% more often than those without Sjögren’s.

Secretagogues are currently the most effective treatment for Sjögren’s syndrome, Dr. Bowling said. In particular, the saliva-stimulating drug Evoxac (cevimeline HCl, Daiichi) three times a day is very useful, he said.